3.4.2 Allergen Immunotherapy (contains Omalizumab)

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

59 library items in 3.4.2 Allergen Immunotherapy (contains Omalizumab)

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

3: Respiratory system (remove) , 3.4 Antihistamines, hyposensitisation, and allergi (remove) , 3.4.2 Allergen Immunotherapy (contains Omalizumab) (remove)

Sort by: Display summary:

Results 1 - 10 of 59

Result page:
Previous
|
1
2
3
4
5
6
|
Next

1.

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry

Source: Thorax,
Date published: 11/05/2012

Category:

3.2 Corticosteroids | 3.4.2 Allergen Immunotherapy (contains Omalizumab) | Asthma

NeLM Area:

News

Abstract (available freely at time of posting)
2.

NIHR HTA: Systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

Source: Health Technology Assessment,
Date published: 15/03/2012

Category:

3.4.2 Allergen Immunotherapy (contains Omalizumab) | Allergy | Drug reviews

NeLM Area:

News

Abstract
3.

CADTH Rapid Review: Effectiveness of omalizumab for allergic asthma

Source: Canadian Agency for Drugs and Technologies in Health (CADTH),
Date published: 05/12/2011

Category:

3.4.2 Allergen Immunotherapy (contains Omalizumab) | Asthma | Drug reviews

NeLM Area:

News

Link
4.

Updated national IM monograph on Promethazine

Source: Medusa,
Date published: 03/11/2011

Category:

3.4.2 Allergen Immunotherapy (contains Omalizumab) | 4.1.1 Hypnotics | 4.6 Drugs used in nausea and vertigo | Drug Administration

NeLM Area:

News

Link- registration required

Link to FAQ on MEDUSA
5.

Draft NICE guidance supports the use of Pharmalgen for bee and wasp sting allergy

Source: NICE,
Date published: 30/09/2011

Category:

3.4.2 Allergen Immunotherapy (contains Omalizumab) | Allergy | National Institute of Clinical Excellence (NICE)

NeLM Area:

News

ACD

Press release
6.

Three year efficacy of pre- and co-seasonal 5-grass-pollen sublingual immunotherapy tablets (Oralair) in patients with grass pollen induced rhinoconjunctivitis

Source: J Allergy Clin Immunol,
Date published: 11/08/2011

Category:

3.4.2 Allergen Immunotherapy (contains Omalizumab) | Allergy | Ear, Nose and Throat (ENT) disorders

NeLM Area:

News

Link
7.

Horizon scanning: Efficacy of lebrikizumab in patients with asthma

Source: NEJM,
Date published: 04/08/2011

Category:

3.4.2 Allergen Immunotherapy (contains Omalizumab) | Asthma | New drugs

NeLM Area:

News

Abstract

Editorial- access may be restricted to subscribers
8.

Sublingual immunotherapy for treating allergic conjunctivitis

Source: Cochrane Library,
Date published: 01/08/2011

Category:

3.4.2 Allergen Immunotherapy (contains Omalizumab) | Bacterial | Drug reviews | Ophthalmology

NeLM Area:

Evidence > Drug Specific Reviews

Link to Abstract
9.

Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?

Source: European Journal of Public Health,
Date published: 28/06/2011

Category:

3.4.2 Allergen Immunotherapy (contains Omalizumab)

NeLM Area:

Evidence > Medicines Management > References

Full text link (PDF)
10.

Subcutaneous immunotherapy for hay fever seems to be effective early

Source: Journal of Allergy and Clinical Immunology,
Date published: 08/06/2011

Category:

3.4.2 Allergen Immunotherapy (contains Omalizumab) | Allergy | New drugs

NeLM Area:

News

Abstract

Results 1 - 10 of 59

Result page:
Previous
|
1
2
3
4
5
6
|
Next